Table of Content

Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Market Definition and Overview
3. Executive Summary
4. Market Dynamics
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. The Increasing Adoption
4.1.1.2. Increased Research and Development
4.1.2. Restraints
4.1.2.1. Lack of Skilled Professional
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Regulatory Analysis
6. COVID-19 Analysis
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturer’s Strategic Initiatives
6.6. Conclusion
7. By Product & Services
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product & Services Segment
7.1.2. Market Attractiveness Index, By Product & Services Segment
7.2. Systems
7.2.1. Introduction
7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
7.3. Kits
7.3.1. Library Preparation Kits
7.3.2. Target Enrichment Kits
7.3.3. Others
7.4. Services
7.4.1. Sequencing Services
7.4.2. Data Analysis (Bioinformatics) Services
7.4.3. Others Services
8. By Technology
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology Segment
8.1.2. Market Attractiveness Index, By Technology Segment
8.2. Second-generation Sequencing
8.2.1. Introduction
8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
8.2.3. Sequencing by Synthesis (SBS)
8.2.4. Sequencing by Hybridization and Ligation (SBL)
8.3. Third-generation Sequencing
9. By Application
9.1. Introduction
9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
9.1.2. Market Attractiveness Index, By Application Segment
9.2. Drug Discovery and Development
9.2.1. Introduction
9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
9.3. Diagnostics
9.4. Personalized Medicine
9.5. Others
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product & Services
10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.2.6.1. The U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product & Services
10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.3.6.1. Germany
10.3.6.2. The U.K.
10.3.6.3. France
10.3.6.4. Italy
10.3.6.5. Spain
10.3.6.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product & Services
10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. Brazil
10.4.6.2. Argentina
10.4.6.3. Rest of South America
10.5. Asia Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product & Services
10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.5.6.1. China
10.5.6.2. India
10.5.6.3. Japan
10.5.6.4. Australia
10.5.6.5. Rest of Asia Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product & Services
10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11. Competitive Landscape
11.1. Key Developments and Strategies
11.2. Company Share Analysis
11.3. Product Benchmarking
12. Company Profiles
12.1. Agilent Technologies Inc.
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Key Highlights
12.1.4. Financial Overview
12.2. Illumina Inc.
12.3. Bio-Rad Laboratories Inc.
12.4. Macrogen Inc.
12.5. Beijing Genomics Institute
12.6. Ambry Genetics Corp.
12.7. Eurofins Scientific Group
12.8. F. Hoffmann-La Roche AG
12.9. GENEWIZ Inc.
12.10. Pacific Biosciences of California Inc.
LIST NOT EXHAUSTIVE
13. DataM
13.1. Appendix
13.2. About Us and Services
13.3. Contact Us